COVID-19 VACCINE (VERO CELL), INACTIVATED

Indications

• COVID-19
• Severe acute respiratory syndrome
• Pneumonia due to SARS-CoV-2

Dosage

Children: Refer to specific antiviral treatment guidelines for dosing.

Adults: Refer to specific antiviral treatment guidelines for dosing.

Mechanism of action

SARS-CoV-2 enters host cells via the interaction of its spike (S) protein with the angiotensin-converting enzyme 2 (ACE2) receptor on human cells. Once inside the cell, the viral RNA is released and translated into viral proteins, leading to the replication of the virus. This process hijacks the host's cellular machinery to produce new viral particles, which are then released to infect other cells.

Pharmacodynamics

The pharmacodynamics of treatments targeting SARS-CoV-2 focus on inhibiting viral replication, reducing inflammation, and modulating the immune response. Antiviral agents may target various stages of the viral life cycle, including entry inhibitors, polymerase inhibitors, and protease inhibitors, while corticosteroids are often used to manage the inflammatory response in severe cases.

Pharmacokinetics

Pharmacokinetics vary depending on the specific antiviral treatment used for SARS-CoV-2. Generally, antiviral medications have different absorption rates, distribution volumes, metabolism pathways, and excretion routes. Factors such as age, weight, organ function, and the presence of comorbidities can influence the pharmacokinetics of these drugs.

Adverse effects

• Nausea
• Fatigue
• Diarrhea
• Respiratory symptoms
• Headache
• Myalgia
• Fever
• Anaphylaxis

Precautions

• Monitor patients for respiratory distress.
• Use caution in patients with a history of severe allergic reactions.
• Assess renal and hepatic function before use.
• Consider potential interactions with other medications.

Pregnancy

Limited data available. Consult with a healthcare provider before use.

Breast-feeding

Consult with a healthcare provider before use, as safety in breastfeeding has not been established.

Storage

Store at room temperature, away from moisture and light. Keep out of reach of children.

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.